PAVM
PAVmed Inc

8,848
Loading...
Loading...
News
all
press releases
Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement
Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement PR Newswire NEW YORK, Feb. 25, 2025 NEW...
PR Newswire·7mo ago
News Placeholder
More News
News Placeholder
PAVmed and Subsidiary Veris Health Complete Private Placement Financing
PAVmed and Subsidiary Veris Health Complete Private Placement Financing PAVmed and Subsidiary Veris Health Complete Private Placement Financing PR Newswire NEW YORK, Feb. 24, 2025 Gross proceeds of...
PR Newswire·7mo ago
News Placeholder
Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health
Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health PR Newswire NEW YORK, Feb. 20, 2025 LEAA...
PR Newswire·7mo ago
News Placeholder
PAVmed Regains Compliance with Nasdaq Stockholders' Equity Requirement
PAVmed Regains Compliance with Nasdaq Stockholders' Equity Requirement PAVmed Regains Compliance with Nasdaq Stockholders' Equity Requirement PR Newswire NEW YORK, Feb. 18, 2025 NEW YORK, Feb. 18...
PR Newswire·7mo ago
News Placeholder
Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital...
PR Newswire·7mo ago
News Placeholder
Lucid Diagnostics Announces Record Quarterly EsoGuard Test Volume
Lucid Diagnostics Announces Record Quarterly EsoGuard Test Volume Lucid Diagnostics Announces Record Quarterly EsoGuard Test Volume PR Newswire NEW YORK, Jan. 13, 2025 Quarterly test volume of over...
PR Newswire·8mo ago
News Placeholder
Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid...
PR Newswire·9mo ago
News Placeholder
Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters
Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for...
PR Newswire·9mo ago
News Placeholder
Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard Esophageal DNA Test Accepted for Peer-Reviewed Publication
Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard Esophageal DNA Test Accepted for Peer-Reviewed Publication Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard...
PR Newswire·9mo ago
News Placeholder
Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard Esophageal DNA Test
Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard Esophageal DNA Test Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare...
PR Newswire·10mo ago

Latest PAVM News

View

Advertisement. Remove ads.

Advertisement. Remove ads.